PharmAbcine Inc. — Investor Relations & Filings
Filings indexed
461
across all filing types
Latest filing
2024-03-06
Delisting Announcement
Country
KR
South Korea
Listing
KO
208340
PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기타시장안내 (상장적격성 실질심사 대상 결정) | 2024-03-06 | Korean | |
| 주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정) | 2024-03-06 | Korean | |
| 기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내) | 2024-02-13 | Korean | |
| 임시주주총회결과 | 2024-01-29 | Korean | |
| 대표이사변경 | 2024-01-29 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2024-01-29 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8198117 | 기타시장안내 (상장적격성 실질심사 대상 결정) | 2024-03-06 | Korean | ||
| 8197739 | 주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정) | 2024-03-06 | Korean | ||
| 8215404 | 기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내) | 2024-02-13 | Korean | ||
| 8222887 | 임시주주총회결과 | 2024-01-29 | Korean | ||
| 8222847 | 대표이사변경 | 2024-01-29 | Korean | ||
| 8222844 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2024-01-29 | Korean | ||
| 8225228 | 기타시장안내(상장적격성 실질심사 대상결정 기한 안내) | 2024-01-22 | Korean | ||
| 8225695 | 기타시장안내((주)파멥신 상장적격성 실질심사관련 안내) | 2024-01-19 | Korean | ||
| 8225693 | 불성실공시법인지정(공시번복) | 2024-01-19 | Korean | ||
| 8225690 | 주권매매거래정지(상장적격성 실질심사 대상(사유발생)) | 2024-01-19 | Korean | ||
| 8227157 | [기재정정]최대주주변경 | 2024-01-16 | Korean | ||
| 8227983 | 신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득(제2회차) | 2024-01-12 | Korean | ||
| 8227979 | [기재정정]주주총회소집결의(임시주주총회) | 2024-01-12 | Korean | ||
| 8227958 | 주주총회소집공고 | 2024-01-12 | Korean | ||
| 8227954 | 의결권대리행사권유참고서류 | 2024-01-12 | Korean | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmAbcine Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16923/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16923 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16923 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16923 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16923}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmAbcine Inc. (id: 16923)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.